U.S. Lithium Corp.

• US Lithium Corp (BioELife) Launches ECommerce Website For Wholesale Customers And Consumers

  US Lithium Corp. is pleased to announce that its CBD business has launched its beta ecommerce website, www.bioelife.net. The new site will allow wholesale customers, as well as consumers, to register, view and purchase all of BioELife’s current product offerings. This includes adult CBD gum drops, the Company’s highly concentrated topical 2,000 mg CBD intensive pain cream, premium pre-rolls and flower [...]

  weiterlesen

  19.02.2020

  von GlobeNewswire
• US Lithium Corp. (BioELife Corp.) Releases ChiroRub 2000, the Next Generation CBD Pain Cream

  US Lithium Corp. is pleased to announce that it has completed production and began shipping its latest pain cream, ChiroRub 2000. The proprietary formulation, containing 2,000 mg of CBD, has been doctor and patient tested and is one of the most effective pain relief creams currently available on the market today. ChiroRub 2000 was developed in conjunction with leading physicians, chiropractors, and medical [...]

  weiterlesen

  12.02.2020

  von GlobeNewswire
• US Lithium Corp. Announces It Has Approved Name Change To BioELife Corp. To Reflect New Direction

  US Lithium Corp. is pleased to announce that its Board of Directors and shareholders have approved an amendment to the Articles of Incorporation changing the name of the corporation from U.S. Lithium Corp. to BioELife Corp. The name change will better reflect the Company’s new strategic focus on the rapidly growing CBD market. The Company expects this action will become effective within the next 30 days. The [...]

  weiterlesen

  05.02.2020

  von GlobeNewswire
• US Lithium Corp. Wins Manufacturing & Distribution Contract From International Healthcare Network

  US Lithium Corp. is pleased to announce that its CBD manufacturing business has been awarded an exclusive purchase and distribution agreement by International Healthcare Network for at least four of its products. One much anticipated product is a highly concentrated topical pain cream developed in conjunction with leading chiropractors across the country. “After extensive patient testing, our products were [...]

  weiterlesen

  30.01.2020

  von GlobeNewswire
• US Lithium Corp. Enters CBD Industry Through Strategic Asset Acquisition

  US Lithium Corp. is pleased to announce that, effective January 20, 2020, it has acquired four cannabinoid related contracts between Hemp Cloud 9 and four unrelated parties in exchange for 4.7M shares of LITH stock. As a result of these acquisitions the Company will change its primary business from minerals to cannabinoids. The Company also intends to change its name, stock symbol and website within the next 30 days [...]

  weiterlesen

  21.01.2020

  von GlobeNewswire

weitere engl. Meldungen